-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Intercept Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2022.
- Intercept Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2023 was $93.4M, a 6.47% increase year-over-year.
- Intercept Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2023 was $379M, a 11.3% increase year-over-year.
- Intercept Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $354M, a 2% decline from 2021.
- Intercept Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $361M, a 22.1% decline from 2020.
- Intercept Pharmaceuticals, Inc. annual Costs and Expenses for 2020 was $464M, a 17.8% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)